This is the authors' abstract. We don't add key points for this paper.
Objective: To compare the diagnostic accuracy of dynamic computed tomography (CT) and gadoxetate-enhanced magnetic resonance imaging (MRI) for characterization of hepatic lesions by using the Liver Imaging Reporting and Data System (LI-RADS) in a multicenter, off-site evaluation. Materials and Methods:In this retrospective multicenter study, we evaluated 231 hepatic lesions (114 hepatocellular carcinomas [HCCs], 58 non-HCC malignancies, and 59 benign lesions) confirmed histologically in 217 patients with chronic liver disease who underwent both gadoxetate-enhanced MRI and dynamic CT at one of five tertiary hospitals.Four radiologists at different institutes independently reviewed all MR images first and the CT images 4 weeks later.They evaluated the major and ancillary imaging features and categorized each hepatic lesion according to the LI-RADS v2014.Diagnostic performance was calculated and compared using generalized estimating equations.Results: MRI showed higher sensitivity and accuracy than CT for diagnosing hepatic malignancies; the pooled sensitivities, specificities, and accuracies for categorizing LR-5/5V/M were 59.0% vs. 72.4% (CT vs. MRI; p < 0.001), 83.5% vs. 83.9%(p = 0.906), and 65.3% vs. 75.3%(p < 0.001), respectively.CT and MRI showed comparable capabilities for differentiating between HCC and other malignancies, with pooled accuracies of 79.9% and 82.4% for categorizing LR-M, respectively (p = 0.139).Conclusion: Gadoxetate-enhanced MRI showed superior accuracy for categorizing LR-5/5V/M in hepatic malignancies in comparison with dynamic CT.Both modalities had comparable accuracies for distinguishing other malignancies from HCC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
An et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: